...
首页> 外文期刊>BMJ Open >A pilot randomised controlled trial of a preconsultation web-based intervention to improve the care quality and clinical outcomes of diabetes outpatients (DIAT)
【24h】

A pilot randomised controlled trial of a preconsultation web-based intervention to improve the care quality and clinical outcomes of diabetes outpatients (DIAT)

机译:一项基于咨询前网络干预的随机对照试验,以改善糖尿病门诊患者的护理质量和临床结局(DIAT)

获取原文

摘要

Introduction Diabetes is a chronic condition associated with many long-term complications. People with diabetes need to actively manage their condition, which can be complex. In consultations with healthcare professionals, patients receive advice about their diabetes but do not always discuss things which concern them, perhaps because of the perceived limited time or embarrassment. We want to test a ‘preconsultation’ intervention in which the patient is supported by a healthcare assistant to complete a web-based intervention aimed at producing an agenda to help them identify important areas for discussion in the consultation. Use of this agenda may enable the patient to play a more active role in that consultation and consequently become more confident, and hence more successful, in managing their condition. Methods and analysis In this pilot randomised controlled trial, 120 people with diabetes will be randomised with equal allocation to receive the intervention or usual clinical care. The primary outcome is reduction in glycosylated haemoglobin(HbA1c). Secondary outcomes are patient-reported communication, enablement, self-care activity, diabetes-dependent quality of life, empowerment, satisfaction, health-related quality of life and resource use. The aim of the pilot study was to estimate parameters to inform the design of the definitive trial. Follow-up on quantitative outcomes will be at 3 and 6?months. A nested qualitative study will collect data on the patients’ experiences of producing an agenda. Resource use data and medication use will also be collected via a review of medical records for a sample of participants. Ethics and dissemination Approval was granted by the NHS Research Ethics Committee North West—Preston (13/NW/0123). Dissemination will include publication of quantitative and qualitative findings, and experience of public involvement in peer-reviewed journals. Results will also be disseminated to trial participants via workshops led by lay coapplicants. Trial Registration ISRCTN75070242.
机译:简介糖尿病是一种慢性病,伴有许多长期并发症。糖尿病患者需要积极控制自己的病情,这可能很复杂。在与医疗保健专业人员进行咨询后,患者可能会收到有关其糖尿病的建议,但并不总是讨论与他们有关的事情,这可能是因为感觉到的时间有限或感到尴尬。我们希望测试一种“咨询前”干预措施,在这种干预措施中,医护助理会为患者提供帮助,以完成基于网络的干预措施,旨在制定议程以帮助他们确定咨询中需要讨论的重要领域。使用该议程可以使患者在咨询过程中发挥更积极的作用,从而在管理自己的病情时变得更有信心,从而更加成功。方法和分析在该试验性随机对照试验中,将对120名糖尿病患者进行均等分配,以接受干预或常规临床护理。主要结果是糖基化血红蛋白(HbA1c)减少。次要结果是患者报告的沟通,能力,自我保健活动,依赖糖尿病的生活质量,授权,满意度,与健康相关的生活质量和资源使用。初步研究的目的是估算参数,以指导确定性试验的设计。量化结果的随访时间为3和6个月。巢式定性研究将收集有关患者制定议程经验的数据。资源使用数据和药物使用也将通过对参与者样本的医疗记录进行审查来收集。道德与传播批准是由NHS研究道德委员会西北普雷斯顿(13 / NW / 0123)批准的。传播将包括发表定量和定性研究结果,以及公众参与同行评审期刊的经验。结果还将通过非申请者共同主持的讲习班分发给试验参与者。试用注册ISRCTN75070242。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号